Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome

<p>Abstract</p> <p>Background</p> <p>Recent studies have suggested a role for an altered intestinal microbiota in the pathophysiology of irritable bowel syndrome (IBS). However, no consensus has been reached regarding the association between specific enteric bacterial g...

Full description

Bibliographic Details
Main Authors: Carroll Ian M, Chang Young-Hyo, Park Jiwon, Sartor R Balfour, Ringel Yehuda
Format: Article
Language:English
Published: BMC 2010-12-01
Series:Gut Pathogens
Online Access:http://www.gutpathogens.com/content/2/1/19
_version_ 1818155308377178112
author Carroll Ian M
Chang Young-Hyo
Park Jiwon
Sartor R Balfour
Ringel Yehuda
author_facet Carroll Ian M
Chang Young-Hyo
Park Jiwon
Sartor R Balfour
Ringel Yehuda
author_sort Carroll Ian M
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Recent studies have suggested a role for an altered intestinal microbiota in the pathophysiology of irritable bowel syndrome (IBS). However, no consensus has been reached regarding the association between specific enteric bacterial groups and IBS. The aim of this study was to investigate the fecal and mucosal-associated microbiota using two independent techniques in intestinal samples from diarrhea-predominant IBS (D-IBS) and healthy controls.</p> <p>Methods</p> <p>Fecal and colonic mucosal biopsy samples were obtained from 10 D-IBS patients and 10 healthy controls. Colonic tissue was collected during a un-sedated un-prepped flexible sigmoidoscopy. Fecal and tissue samples were processed immediately upon collection for culture under aerobic and anaerobic conditions or frozen for further molecular analysis. DNA was extracted from all frozen samples and used to enumerate specific bacterial groups using quantitative real-time PCR (qPCR).</p> <p>Results</p> <p>Culture analysis of intestinal samples demonstrated a significant reduction in the concentration of aerobic bacteria in fecal samples from D-IBS patients when compared to healthy controls (1.4 × 10<sup>7 </sup>vs. 8.4 × 10<sup>8 </sup>CFUs/g feces, <it>P </it>= 0.002). qPCR analysis demonstrated a significant 3.6 fold increase (<it>P </it>= 0.02) in concentrations of fecal <it>Lactobacillus </it>species between D-IBS patients and healthy controls.</p> <p>Conclusions</p> <p>Our culture and molecular data indicate that quantitative differences exist in specific bacterial groups in the microbiota between D-IBS and healthy subjects.</p>
first_indexed 2024-12-11T14:40:20Z
format Article
id doaj.art-b2b27e627a234d23b5e994d544edee2b
institution Directory Open Access Journal
issn 1757-4749
language English
last_indexed 2024-12-11T14:40:20Z
publishDate 2010-12-01
publisher BMC
record_format Article
series Gut Pathogens
spelling doaj.art-b2b27e627a234d23b5e994d544edee2b2022-12-22T01:01:57ZengBMCGut Pathogens1757-47492010-12-01211910.1186/1757-4749-2-19Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndromeCarroll Ian MChang Young-HyoPark JiwonSartor R BalfourRingel Yehuda<p>Abstract</p> <p>Background</p> <p>Recent studies have suggested a role for an altered intestinal microbiota in the pathophysiology of irritable bowel syndrome (IBS). However, no consensus has been reached regarding the association between specific enteric bacterial groups and IBS. The aim of this study was to investigate the fecal and mucosal-associated microbiota using two independent techniques in intestinal samples from diarrhea-predominant IBS (D-IBS) and healthy controls.</p> <p>Methods</p> <p>Fecal and colonic mucosal biopsy samples were obtained from 10 D-IBS patients and 10 healthy controls. Colonic tissue was collected during a un-sedated un-prepped flexible sigmoidoscopy. Fecal and tissue samples were processed immediately upon collection for culture under aerobic and anaerobic conditions or frozen for further molecular analysis. DNA was extracted from all frozen samples and used to enumerate specific bacterial groups using quantitative real-time PCR (qPCR).</p> <p>Results</p> <p>Culture analysis of intestinal samples demonstrated a significant reduction in the concentration of aerobic bacteria in fecal samples from D-IBS patients when compared to healthy controls (1.4 × 10<sup>7 </sup>vs. 8.4 × 10<sup>8 </sup>CFUs/g feces, <it>P </it>= 0.002). qPCR analysis demonstrated a significant 3.6 fold increase (<it>P </it>= 0.02) in concentrations of fecal <it>Lactobacillus </it>species between D-IBS patients and healthy controls.</p> <p>Conclusions</p> <p>Our culture and molecular data indicate that quantitative differences exist in specific bacterial groups in the microbiota between D-IBS and healthy subjects.</p>http://www.gutpathogens.com/content/2/1/19
spellingShingle Carroll Ian M
Chang Young-Hyo
Park Jiwon
Sartor R Balfour
Ringel Yehuda
Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
Gut Pathogens
title Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
title_full Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
title_fullStr Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
title_full_unstemmed Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
title_short Luminal and mucosal-associated intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome
title_sort luminal and mucosal associated intestinal microbiota in patients with diarrhea predominant irritable bowel syndrome
url http://www.gutpathogens.com/content/2/1/19
work_keys_str_mv AT carrollianm luminalandmucosalassociatedintestinalmicrobiotainpatientswithdiarrheapredominantirritablebowelsyndrome
AT changyounghyo luminalandmucosalassociatedintestinalmicrobiotainpatientswithdiarrheapredominantirritablebowelsyndrome
AT parkjiwon luminalandmucosalassociatedintestinalmicrobiotainpatientswithdiarrheapredominantirritablebowelsyndrome
AT sartorrbalfour luminalandmucosalassociatedintestinalmicrobiotainpatientswithdiarrheapredominantirritablebowelsyndrome
AT ringelyehuda luminalandmucosalassociatedintestinalmicrobiotainpatientswithdiarrheapredominantirritablebowelsyndrome